益盛药业 (002566)

JILIN JIAN YISHENG PHARMACEUTICAL CO.,LTD.

ASZ

Tags

Rural RevitalizationMedical Aesthetics ConceptPharmaceutical ManufacturingMicro Cap StocksNew RetailHepatitis Concept

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 33095.16
  • Circulating A-Shares(W): 23179.05
  • Earnings Per Share(RMB): 0.0729
  • Net Assets Per Share(RMB): 6.7280
  • Operating Revenue(W RMB): 47619.52
  • Total Profit(W RMB): 2781.67
  • Net Profit Attributable to Parent(W RMB): 2412.83
  • Net Profit Growth Rate(%): -32.72
  • Weighted Return on Equity(%): 1.0800
  • Operating Cash Flow Per Share(RMB): 0.1260
  • Undistributed Profit Per Share(RMB): 2.7666
  • Capital Reserve Per Share(RMB): 2.5221

2. Main Business

The main business covers:

  • Research, development, production and sales of pharmaceuticals

3. Company Basic Information

  • Company Name: Jilin Jian Yisheng Pharmaceutical Co., Ltd.
  • Listing Date: 2011-03-18
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 17-20, Wenhua East Road, Ji'an City, Jilin Province, China
  • Website: www.yisheng-pharm.com
  • Company Profile：The company's predecessor, Ji'an Pharmaceutical Co., Ltd., was established on June 11, 1997. On December 27, 2000, approved by the Jilin Provincial Economic and Trade Commission (Document No. Jijingmao Qigai Zi [2000] 996), Ji'an Pharmaceutical Co., Ltd. was transformed into a joint-stock company by way of overall change, with a registered capital of 34.5 million yuan at the time of establishment. On December 28, 2000, the company was registered with the Jilin Provincial Administration for Industry and Commerce, obtaining the "Business License" (Registration No. 2200001004776). The registered address is No. 17-20, Wenhua East Road, Ji'an City, Jilin Province, with legal representative Zhang Yisheng. On January 6, 2003, the Jilin Provincial People's Government issued the "Approval on Confirming Jilin Jian Yisheng Pharmaceutical Co., Ltd." (Joint-stock Company Approval Document [2003] No. 1), confirming the establishment of the joint-stock company.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Nuoan Duocelue Hybrid Securities Investment Fund A Class Fund 198.63 0.86

5. Concept Sectors

  • New Retail
  • Rural Revitalization
  • Medical Aesthetics Concept
  • Hepatitis Concept
  • Micro-cap Stocks

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information